GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (FRA:RER1) » Definitions » PEG Ratio

Recordati SpA (FRA:RER1) PEG Ratio : 4.40 (As of Dec. 11, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Recordati SpA PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Recordati SpA's PE Ratio without NRI is 24.64. Recordati SpA's 5-Year EBITDA growth rate is 5.60%. Therefore, Recordati SpA's PEG Ratio for today is 4.40.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Recordati SpA's PEG Ratio or its related term are showing as below:

FRA:RER1' s PEG Ratio Range Over the Past 10 Years
Min: 1.03   Med: 1.92   Max: 6.38
Current: 4.39


During the past 13 years, Recordati SpA's highest PEG Ratio was 6.38. The lowest was 1.03. And the median was 1.92.


FRA:RER1's PEG Ratio is ranked worse than
81.64% of 365 companies
in the Drug Manufacturers industry
Industry Median: 1.95 vs FRA:RER1: 4.39

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Recordati SpA PEG Ratio Historical Data

The historical data trend for Recordati SpA's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA PEG Ratio Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.35 2.03 3.49 5.51 4.97

Recordati SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.04 4.97 4.77 4.20 3.54

Competitive Comparison of Recordati SpA's PEG Ratio

For the Drug Manufacturers - General subindustry, Recordati SpA's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Recordati SpA's PEG Ratio falls into.



Recordati SpA PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Recordati SpA's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=24.639076034649/5.60
=4.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Recordati SpA  (FRA:RER1) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Recordati SpA PEG Ratio Related Terms

Thank you for viewing the detailed overview of Recordati SpA's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA Business Description

Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines

No Headlines